Viewing Study NCT05007093


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 11:17 PM
Study NCT ID: NCT05007093
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-07
First Post: 2021-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
Sponsor: Yansong Lin
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None DTC - Differentiated Thyroid Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anlotinib View